Two cycles of dual neoadjuvant immunotherapy (nivolumab/ipilimumab or nivolumab/relatlimab) induced high pathological ...
Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...
Kashaf Shaikh, a young mother, faced a daunting challenge when she was diagnosed with triple-negative breast cancer while ...
The event, which was part of the foundation’s annual Breast Cancer 5K Walk/Run, raised an event-high of more than $175,000 ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces new positive survival data, ...